- In June 2026, BWX Technologies, Inc. was removed from several Russell 1000 Defensive indexes shortly after Applied Atomics announced a licensing agreement for BWXT’s mPower small modular reactor technology, under which BWXT retains intellectual property ownership, exclusive manufacturing rights and royalties.
- The mPower agreement effectively shifts BWXT’s role toward being a technology and manufacturing partner in small modular reactors, potentially influencing how index providers and investors classify its business mix between defense, commercial nuclear and longer-term growth exposure.
- We’ll now examine how BWXT’s mPower licensing pivot and resulting removal from Russell 1000 Defensive indexes may influence its broader investment narrative.
Uncover the next big thing with 22 elite penny stocks that balance risk and reward.
BWX Technologies Investment Narrative Recap
To own BWX Technologies today, you need to be comfortable with a business anchored in long-term U.S. defense and naval nuclear work, while gradually extending into commercial and advanced nuclear technologies. The mPower licensing deal and BWXT’s removal from Russell 1000 Defensive indexes do not appear to change the near term focus on executing its record backlog, but they may sharpen the key risk around how consistently commercial nuclear projects convert into profitable, recurring revenue.
The mPower agreement with Applied Atomics is the clearest link to this shift, because it recasts BWXT as a technology and manufacturing partner in small modular reactors rather than a full project developer. That sits alongside existing catalysts such as contracts for TRISO fuel and the Pele microreactor program, which already highlight how much of BWXT’s future opportunity set depends on advanced nuclear adoption and successful, capital intensive program execution.
Yet, while the growth story looks appealing, investors should also be aware that ...
Read the full narrative on BWX Technologies (it's free!)
BWX Technologies' narrative projects $4.5 billion revenue and $530.5 million earnings by 2029. This requires 12.4% yearly revenue growth and about a $201.6 million earnings increase from $328.9 million today.
Uncover how BWX Technologies' forecasts yield a $232.27 fair value, a 19% upside to its current price.
Exploring Other Perspectives
Some of the lowest ranked analysts were already assuming only about US$4.4 billion of revenue and US$503.0 million of earnings by 2029, so if you worry about nuclear policy setbacks and rising costs crowding out SMR demand, their more cautious view may feel closer to how you think about BWXT after this mPower and index removal news.
Explore 11 other fair value estimates on BWX Technologies - why the stock might be worth as much as 45% more than the current price!
Form Your Own Verdict
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your BWX Technologies research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
- Our free BWX Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate BWX Technologies' overall financial health at a glance.
Ready To Venture Into Other Investment Styles?
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
- Outshine the giants: these 15 early-stage AI stocks could fund your retirement.
- AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- The latest GPUs need a type of rare earth metal called Neodymium and there are only 30 companies in the world exploring or producing it. Find the list for free.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com